New research conducted at the Center for
Tuberculosis Research at the Johns Hopkins University School of Medicine shows that lower doses of the
toxic drug bedaquiline — given together with verapamil, a medication that's used to treat various heart conditions — can lead to the same antibacterial effects as higher
toxic doses of bedaquiline.